Skip to content
Research Article Open access CC BY 3.0

Higher Ratio of Arterial vs Venous Thrombosis in Hemophilia A as Compared with Von Willebrand Disease

A. Girolami, E. Cosi, L. Sambado, V. Daidone, F. Fabris

International Blood Research & Reviews · pp. 289–298 · Published 15 Jul 2014

10.9734/IBRR/2014/11142

Abstract

Objectives: to investigate the ratio between arterial and venous thrombosis in patients with Hemophilia A or B in comparison with that of patients with von Willebrand Disease. Methods: analysis of a time unlimited survey of the literature together with an evaluation of personal records. Thrombotic events had to be proven by objective methods. Acquired forms were excluded. 222 patients were found to meet the inclusion criteria, 131 patients with Hemophilia A or B and 91 patients with von Willebrand Disease. Results: The ratios between arterial and venous thrombosis resulted to be 3.75, 1.12, 2.54 and 1.75, for Hemophilia A, Hemophilia B, combined Hemophilia A and B and von Willebrand Disease, respectively. The difference between Hemophilia A and von Willebrand Disease was statistically significant. Conclusions: The plasmatic defect present in the Hemophilias, especially in Hemophilia A, seems to protect more from venous rather than from arterial thrombosis. This pattern is less evident for von Willebrand Disease. The clinical significance and the pathogenetic implications of these findings are discussed.  

Hemophilia von Willebrand Disease thrombosis arterial venous

References (48)

  1. 1 Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studies [DOI]
  2. 2 Venous Thromboembolism in Von Willebrand Disease [DOI]
  3. 3 Non-catheter associated venous thrombosis in hemophilia A and B. A critical review of all reported cases [DOI]
  4. 4 Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature [DOI]
  5. 5 Myocardial Infarction, Other Arterial Thrombosis and Invasive Coronary Procedures, in Hemaophilia B: A Critical Evaluation of Reported Cases [DOI]
  6. 6 Clinical efficacy and safety of the factor VIII/von Willebrand factor concentrate BIOSTATE® in patients with von Willebrand’s disease: a prospective multi‐centre study [DOI]
  7. 7 Congenital Bleeding Disorders of the Vitamin K‐Dependent Clotting Factors [DOI]
  8. 8 Fanhdi®, efficacy and safety in von Willebrand’s disease: prospective international study results [DOI]
  9. 9 Comparative incidence of thrombosis in reported cases of deficiencies of factors of the contact phase of blood coagulation [DOI]
  10. 10 Cardiac catheterization and intervention in haemophilia patients: prospective evaluation of the 2009 institutional guideline [DOI]
  11. 11 Outcomes of management of acute coronary syndrome in patients with congenital bleeding disorders: A single center experience and review of the literature [DOI]
  12. 12 Thrombosis in rare bleeding disorders [DOI]
  13. 13 Successful percutaneous coronary intervention in a patient with severe haemophilia A using bivalirudin as the sole procedural anticoagulant [DOI]
  14. 14 Percutaneous coronary intervention with stent implantation in haemophilic A patient with unstable angina [DOI]
  15. 15 Thrombosis in VonWillebrand disease [DOI]
  16. 16 Successful Treatment of Patients with von Willebrand Disease using a High-Purity Double-Virus Inactivated Factor VIII/von Willebrand Factor Concentrate (Immunate®) [DOI]
  17. 17 Percutaneous coronary intervention in a patient with acute ST-elevation myocardial infarction and hemophilia A.
  18. 18 Discrepant ratios of arterial vs. venous thrombosis in hemophilias A and B as compared to FVII deficiency [DOI]
  19. 19 Arterial and venous thrombosis in patients with von Willebrand’s disease: A critical review of the literature [DOI]
  20. 20 Myocardial infarction following recombinant activated factor VII in a patient with type 2A von Willebrand disease [DOI]
  21. 21 Cardiac Surgery in a Patient with Haemophilia A [DOI]
  22. 22 Deep vein thrombosis in a patient with severe haemophilia A [DOI]
  23. 23 Venous thrombosis in von Willebrand disease as observed in one centre and as reported in the literature [DOI]
  24. 24 Management of an acute coronary syndrome in a patient with severe haemophilia A [DOI]
  25. 25 Successful Percutaneous Coronary Intervention for Acute Coronary Syndrome in a Patient With Severe Hemophilia A [DOI]
  26. 26 Discrepant ratios of arterial versus venous thrombosis in hemophilia A as compared with hemophilia B [DOI]
  27. 27 Coronary Artery Bypass Surgery, Angioplasty and Long Term Anti-Platelet Treatment in a Type B Hemophilia Patient [DOI]
  28. 28 Acute myocardial infarction in a patient with von Willebrand disease: pathogenetic dilemmas and therapeutic challenges.
  29. 29 Spontaneous deep vein thrombosis in hemophilia A: a case report [DOI]
  30. 30 Transient focal cerebral ischaemia and bilateral pulmonary embolism after desmopressin treatment for von Willebrand’s disease [DOI]
  31. 31 Percutaneous transluminal coronary angioplasty in hemophilia [DOI]
  32. 32 Coronary Stenting in a Hemophilic Patient [DOI]
  33. 33 Percutaneous coronary intervention and the management of acute coronary syndromes in patients with von Willebrand disease.
  34. 34 Fatal Myocardial Infarction Following Therapy with Prothrombin Complex Concentrates in a Young Man with Hemophilia A [DOI]
  35. 35 Treatment of a patient with factor IX deficiency (hemophilia B) with coronary bypass surgery [DOI]
  36. 36 Successful thrombolysis for acute myocardial infarction in type I von Willebrand's disease (vWD) [DOI]
  37. 37 Acute myocardial infarction in a patient with von Willebrand disease [DOI]
  38. 38 Successful percutaneous transluminal coronary angioplasty for acute myocardial infarction in von Willebrand's disease [DOI]
  39. 39 Acute inferior myocardial infarction in a patient with severe haemophilia A disease [DOI]
  40. 40 Percutaneous coronary intervention in a patient with von Willebrand's disease presenting with an acute coronary syndrome.
  41. 41 Management of a Patient with Type IIC von Willebrand's Disease during Coronary Artery Bypass Graft Surgery [DOI]
  42. 42 Portal vein thrombosis in a patient with HCV cirrhosis and combined hemophilia A and thrombophilia V Leiden [DOI]
  43. 43 Cerebral sinus venous thrombosis with parenchymal infarcts in a newborn with severe haemophilia A and subdural haematomas [DOI]
  44. 44 Acute myocardial infarction in a Chinese patient with haemophilia A and risk factors for coronary artery disease: a case report with autopsy [DOI]
  45. 45 Atherosclerosis and a coronary artery bypass operation in a woman with von Willebrand disease.
  46. 46 Acute myocardial infarction complicating prothrombin complex concentrate therapy in an 8-year-old boy with hemophilia A and factor VIII inhibitor.
  47. 47 Acute myocardial infarction in a patient with von Willebrand disease [DOI]
  48. 48 Intracranial hemorrhage in a term newborn with severe von Willebrand disease type 3 associated with sinus venous thrombosis.

Cited by 1

Article metrics

Real usage data collected on this platform.

59

Page views

0

PDF downloads

9

Outbound clicks

1

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.